课题基金 / 基金详情

Naeglearia fowleri proline tRNA synthetase inhibitors

Naeglearia fowleri proline tRNA synthetase inhibitors
福氏耐格里霉脯氨酸 tRNA 合成酶抑制剂
批准号:
10691134
负责人:
Alexey Zakharov
金额:
$14.62万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Alexey Zakharov的其他基金

相关文献

中文摘要
翻译
迄今为止发现的脯氨酸tRNA合成酶抑制剂都是基于知识的,并且只采样了化学性质空间的极小部分,并且以这种方式鉴定的化合物对感染性疾病的临床影响可以忽略不计。在此期间,项目团队对选定的小分子文库进行了定量高通量筛选(qHTS),并对命中化合物进行了验证。 利用机器学习方法来构建计算机定量结构-活性关系(QSAR)模型,以使得能够针对更大的NCATS分子集合虚拟筛选化合物。目前正在筛选更大的化合物集合,以确定具有更高效力的化合物,并改进QSAR模型。
英文摘要
Proline tRNA synthetase inhibitors discovered to date have all been knowledge-based and sampled an extremely small portion of chemical property space and compounds identified this way have had negligible clinical impact against infectious diseases. During this period, the project team conducted quantitative high-throughput screening (qHTS) on select small molecule libraries, and hit compounds were validated. Machine learning approaches were utilized to construct in silico quantitative structure-activity relationship (QSAR) models to enable virtual screening of compounds against larger collections of NCATS molecules. Work is ongoing screening larger compound collections to identify compounds with increased potency and enable refinement of the QSAR model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Triple drug combination screening
NCATS Malaria Active Collection
Screening for small molecule inhibitors of B. burgdorferi HtrA
Identification of ALPK1 inhibitors